| Disrupting the ghrelin-growth hormone axis limits ghrelin's orexigenic but not glucoregulatory actions D Gupta, AM Patterson, S Osborne-Lawrence, AL Bookout, S Varshney, ... Molecular Metabolism 53, 101258, 2021 | 25 | 2021 |
| A scoping review of hormonal clinical trials in menstrual cycle-related brain disorders: Studies in premenstrual mood disorder, menstrual migraine, and catamenial epilepsy JC Barone, MP Butler, A Ross, A Patterson, M Wagner-Schuman, ... Frontiers in Neuroendocrinology, 101098, 2023 | 5 | 2023 |
| Disease modification upon brief exposure to tofacitinib during chronic epilepsy OR Hoffman, JL Koehler, JEC Espina, AM Patterson, ES Gohar, ... bioRxiv, 2023.08. 07.552299, 2023 | 2 | 2023 |
| Patient experiences of buprenorphine dispensing from a mobile medical unit SE Messmer, AT Elmes, AF Infante, A Patterson, M Smith, AL Murphy, ... Addiction Science & Clinical Practice 19 (1), 53, 2024 | | 2024 |
| Does a prior adverse response to hormonal contraceptives predict menstrual cycle affective changes?: A prospective transdiagnostic analysis A Ross, A Nagpal, A Patterson, J Barone, H Tauseef, KM Schmalenberger, ... OSF, 2024 | | 2024 |
| Trait and State Associations of Legal THC Use with Symptom Severity in Female Psychiatric Outpatients with Suicidal Ideation Only, Ideation with History of Attempt, and Controls A Patterson, T Eisenlohr-Moul, J Barone, A Nagpal OSF, 2024 | | 2024 |
